Thursday, April 23, 2026
April 23, 2026 marks a pivotal advancement in cardiac care across Lebanon and the Levant. The successful completion of a first-of-its-kind atrial fibrillation (AF) ablation using Abbott’s cutting-edge VOLT technology, led by Dr. Johnny Abboud and supported by a highly skilled Cath Lab and anesthesia team, underscores a commitment to precision, innovation, and better patient outcomes.
A meaningful step forward—shaping the future of every heartbeat.